Faculty Information - 萩原　將太郎

（Last updated : 2024-03-11 15:22:00）

萩原　將太郎
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Hematology

Position

■ Published papers

1.	Original article	Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes. 2024/02/27
2.	Original article	Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma. 2023/01
3.	Original article	Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients. 2022/02
4.	Case report	Successful Rituximab Treatment in Thrombotic Thrombocytopenic Purpura Patients Complicated by Other Autoimmune Disorders: Two Case Reports. 2021/09
5.	Original article	Polymerase-chain reaction testing to prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection in Shinjuku, an epicenter in Tokyo: The Tokyo Women's Medical University model. 2021/05
6.	Original article	Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR. 2021/02
7.	Original article	Status and cost analysis of antimicrobial treatment of terminally ill patients with hematological malignancy in an acute hospital. 2020/12
8.	Original article	Cu and Zn isotope ratio variations in plasma for survival prediction in hematological malignancy cases. 2020/10
9.	Original article	Efficacy of VRD(Bortezomib, Lenalidomide, and Dexamethasone) Consolidation Therapy and Maintenance Therapy with Immunomodulatory Drugs(Thalidomide or Lenalidomide) after Autologous Peripheral Blood Stem Cell Transplantation in the Era of Bortezomib-Containing Induction Therapy-A Single Institution Experience. 2020/05
10.	Original article	Phase I study of cellular therapy using ex vivo expanded NK cell from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients. 2020/04
11.	Original article	Occupational exposure of platinum-based anti-cancer drugs: five-year monitoring of hair and environmental samples in a single hospital. 2020
12.	Original article	Herpes zoster after autologous haematopoietic stem cell transplantation without antiviral prophylaxis. 2019/09
13.	Original article	The current state of human immunodeficiency virus-associated lymphoma in Japan: a nationwide retrospective study of the Japanese Society of Hematology Blood Disease Registry. 2019/08
14.	Original article	Late-stage myeloma invades kidney without significant effect on renal function: findings from 53 autopsies in a single institute. 2019/02
15.	Original article	The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma. 2018/12
16.	Original article	Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma. 2018/12
17.	Original article	HIV positivity may not have a negative impact on survival in Epstein-Barr virus-positive Hodgkin lymphoma: A Japanese nationwide retrospective survey. 2018/09
18.	Original article	Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. 2018/08
19.	Original article	Improved progression-free and event-free survival in myeloma patients undergoing PBSCH receiving a cyclophosphamide + G-CSF regimen than G-CSF alone. 2018/05
Display 5 items
Display all(19)

■ Academic conference presentation

1.	4 cases of COVID-19 infection in patients with hematological diseases 2021/09/23
2.	A case of primary mediastinal large B-cell lymphoma with pancreas involvement 2021/09/23
3.	Retrospective analysis of chronic myelomonocytic leukemia 2021/09/23
4.	Safety and efficacy of obinutuzumab-based chemoimmunotherapy for follicular lymphoma patients 2021/09/23
5.	Successful treatment with daratumumab in multiple myeloma patient with severe renal impairment 2021/09/23
6.	Clinical Features of Post-Transplant Lymphoproliferative Disease Are Different between Kidney-Transplant Recipients from a Cadaveric Donor and Those from a Living Donor 2019/12/08
7.	Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress 2019/12/08
8.	The quality of life on effect and the cost of tandem transplantation in multiple myeloma patients 2019/09/14
9.	Successful combined Treatment of blinatumomab and donor lymphocyte infusion after haploidentical hematopoietic cell transplantation in a relapsed Ph+ALL patient with BCR/ABL1 compound mutation 2019/08/30
10.	Non-Hodgkin lymphoma in patients with myeloproliferative neoplasms 2019/06/15
11.	Allogeneic bone marrow transplantation from unrelated donor for a patient with idiopathic CD4+ lymphocytopenia 2018/11/02
12.	Eculizumab is effective for Budd-Chiari syndrome with paroxysmal nocturnal hemoglobinuria 2018/10/13
13.	Early increased platelet count is a predictive factor for a long-term response in high-dose dexamethasone treatment for newly-diagnosed immune thrombocytopenia patients 2017/12/09
14.	Allogenic SCT for multiple relapsing or pregressing after prior autologous SCT: JSHCT MM-WG 2017/10/22
15.	Analysis of NK cell function in multiple myeloma patients 2017/10/20
16.	Clinical characteristics of CNS relapse in patients with diffuse large B-cell lymphoma 2017/10/20
Display 5 items
Display all(16)

■ Education

1.	2000/02～2003/01	Clinical epidemiology, Centre for Clinical Epidemiology and Biostatistics, The University of Newcastle, Completed, Graduate Diploma in Clinical epidemiology
2.	1999/05 Degree Acquisition	Jichi Medical University,
3.	1984/04～1990/03	Faculty of Medicine, Hamamatsu University School of Medicine, Graduated,